769 CAR T cells undergoing epigenetic reprogramming by low-dose decitabine enhances persistent anti-tumor efficacy in vivo

• Yao Wang,
• Hanren Dai,
• Chuan Tong,
• Weidong Han,
• Zhiqianag Wu

Affiliations

Yao Wang

Department of Endocrinology and Metabolism, Zhongda Hospital Affiliated to Southeast University Medical School, Nanjing, China

Hanren Dai

Aff1 0000 0004 1761 8894grid.414252.4Department of Bio-therapeutic, Department of Molecular & ImmunologyChinese PLA General Hospital No. 28 Fuxing Road 100853 Beijing China

Chuan Tong

Aff1 0000 0004 1761 8894grid.414252.4Department of Bio-therapeutic, Department of Molecular & ImmunologyChinese PLA General Hospital No. 28 Fuxing Road 100853 Beijing China

Weidong Han

Aff1 0000 0004 1761 8894grid.414252.4Department of Bio-therapeutic, Department of Molecular & ImmunologyChinese PLA General Hospital No. 28 Fuxing Road 100853 Beijing China

Zhiqianag Wu

Chinese PLA general hospital, Beijing, China